Clinical trials
Myocardial Infarction trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
146 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 4 |
| 2004 | 3 |
| 2005 | 5 |
| 2006 | 3 |
| 2007 | 6 |
| 2008 | 3 |
| 2009 | 7 |
| 2010 | 9 |
| 2011 | 7 |
| 2012 | 2 |
| 2013 | 9 |
| 2014 | 4 |
| 2015 | 7 |
| 2016 | 6 |
| 2017 | 10 |
| 2018 | 7 |
| 2019 | 5 |
| 2020 | 12 |
| 2021 | 9 |
| 2022 | 4 |
| 2023 | 8 |
| 2024 | 7 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 94 |
| Recruiting | 14 |
| Terminated | 14 |
| Unknown status | 13 |
| Active, not recruiting | 7 |
| Not yet recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 14 |
| Hospices Civils de Lyon | 13 |
| Central Hospital, Nancy, France | 8 |
| French Cardiology Society | 7 |
| AstraZeneca | 6 |
| University Hospital, Bordeaux | 6 |
| University Hospital, Caen | 5 |
| Centre Hospitalier Universitaire Dijon | 4 |
| Novartis Pharmaceuticals | 4 |
| University Hospital, Strasbourg, France | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myocardial Infarction | 146 |
| Acute Coronary Syndrome | 25 |
| Coronary Artery Disease | 20 |
| Stroke | 18 |
| Cardiovascular Diseases | 15 |
| ST Elevation Myocardial Infarction | 12 |
| Angina, Unstable | 10 |
| Myocardial Ischemia | 10 |
| Heart Failure | 8 |
| Atherosclerosis | 6 |
Trials
Showing 51 to 75 of 146. Each trial links to its page on Pharma Observatory.
46 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.